At a glance
- Originator UCB
- Class Antiglaucomas; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 10 May 1996 New profile
- 10 May 1996 Discontinued-Preclinical for Angina pectoris in Belgium (Unknown route)